Holen Sie sich die Stockscreener-App
23.90
1.22%
0.06
Schlusskurs vom Vortag:
$23.84
Offen:
$23.82
24-Stunden-Volumen:
374.73K
Relative Volume:
0.10
Marktkapitalisierung:
$17.77B
Einnahmen:
$956.00K
Nettoeinkommen (Verlust:
$-221.32M
KGV:
-74.69
EPS:
-0.32
Netto-Cashflow:
$-142.25M
1W Leistung:
-2.72%
1M Leistung:
-10.86%
6M Leistung:
+26.14%
1J Leistung:
+91.51%
1-Tages-Spanne:
$23.45
$24.29
1-Wochen-Bereich:
$23.09
$25.76
52-Wochen-Spanne:
$11.76
$36.91
Summit Therapeutics Inc Stock (SMMT) Company Profile
Firmenname
Summit Therapeutics Inc
Sektor
Branche
Telefon
305-203-2034
Adresse
601 BRICKELL KEY DRIVE, MIAMI
Vergleichen Sie SMMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SMMT
Summit Therapeutics Inc
|
23.91 | 17.61B | 956.00K | -221.32M | -142.25M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
399.62 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
583.51 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.09 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
714.32 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.93 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Neutral |
| 2025-07-01 | Eingeleitet | UBS | Buy |
| 2025-06-11 | Eingeleitet | Leerink Partners | Underperform |
| 2025-03-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-03-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-28 | Eingeleitet | Goldman | Buy |
| 2025-01-08 | Eingeleitet | Truist | Buy |
| 2024-12-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-06 | Eingeleitet | Jefferies | Buy |
| 2024-11-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-09-27 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-08-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-07 | Eingeleitet | Citigroup | Buy |
| 2024-03-26 | Eingeleitet | Stifel | Buy |
| 2018-06-28 | Herabstufung | Janney | Buy → Neutral |
| 2018-05-02 | Eingeleitet | Janney | Buy |
| 2018-04-12 | Bestätigt | Needham | Buy |
| 2018-02-13 | Eingeleitet | BTIG Research | Buy |
| 2018-01-04 | Eingeleitet | SunTrust | Buy |
| 2017-12-01 | Fortgesetzt | H.C. Wainwright | Buy |
| 2016-11-16 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-10-05 | Bestätigt | Needham | Buy |
| 2016-09-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-03-30 | Eingeleitet | Needham | Buy |
| 2015-03-30 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten
Analyzing drawdowns of Summit Therapeutics Inc. with statistical tools2025 Market Sentiment & Consistent Income Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Summit Therapeutics Inc.2025 Technical Patterns & High Yield Stock Recommendations - Newser
Summit Therapeutics Inc. to Discuss Full Presentation Data from HARMONi, the Global Phase III Clinical Trial Featured in the Presidential Symposium at WCLC 2025 - MarketScreener
Summit Therapeutics to Host Update Call at WCLC 2025 on September 8, 2025 - Business Wire
Applying big data sentiment scoring on Summit Therapeutics Inc.2025 Earnings Surprises & High Return Stock Watch Alerts - Newser
Will breakout in Summit Therapeutics Inc. lead to full recoveryJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Using Python tools to backtest Summit Therapeutics Inc. strategiesShare Buyback & Verified Momentum Stock Ideas - Newser
Market reaction to Summit Therapeutics Inc.’s recent newsTreasury Yields & AI Enhanced Market Trend Forecasts - Newser
Heatmap analysis for Summit Therapeutics Inc. and competitorsLong Setup & Risk Controlled Daily Trade Plans - Newser
Can Summit Therapeutics Inc. recover in the next quarterWeekly Trade Report & Verified Chart Pattern Signals - Newser
market reaction to summit therapeutics inc.’s recent news2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Is Summit Therapeutics Inc. stock poised for growth2025 Volume Leaders & Expert Curated Trade Ideas - Newser
What is the PEG ratio of Summit Therapeutics Inc.Market Risk Report & Momentum Based Trading Ideas - khodrobank.com
Will Summit Therapeutics Inc. outperform tech stocksJuly 2025 Momentum & Capital Protection Trade Alerts - khodrobank.com
Analyzing Summit Therapeutics Inc. with multi timeframe chartsJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser
What is Summit Therapeutics Inc. s debt to equity ratio2025 Volatility Report & Daily Entry Point Trade Alerts - khodrobank.com
Ranking Summit Therapeutics Inc. among high performing stocks via toolsWeekly Stock Report & Community Consensus Stock Picks - Newser
What to expect from Summit Therapeutics Inc. in the next 30 days2025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser
How to read the order book for Summit Therapeutics Inc.Weekly Market Report & High Yield Stock Recommendations - Newser
Visual trend scoring systems applied to Summit Therapeutics Inc.Buy Signal & Momentum Based Trading Signals - Newser
Top chart patterns to watch in Summit Therapeutics Inc.Trade Exit Summary & Low Risk High Win Rate Picks - Newser
Does Summit Therapeutics Inc. offer margin of safety2025 Market Sentiment & Technical Pattern Based Signals - khodrobank.com
What are Summit Therapeutics Inc.’s recent SEC filings showingJuly 2025 Volume & AI Driven Price Predictions - خودرو بانک
Update Recap: Should you avoid Summit Therapeutics Inc. stock right nowJuly 2025 PostEarnings & Verified Swing Trading Watchlists - خودرو بانک
Will Summit Therapeutics Inc. benefit from AI trendsWeekly Profit Report & Risk Controlled Swing Alerts - خودرو بانک
How to build a dashboard for Summit Therapeutics Inc. stockJuly 2025 Patterns & Expert Curated Trade Setups - Newser
Exit strategy if you’re trapped in Summit Therapeutics Inc.July 2025 Closing Moves & Daily Momentum Trading Reports - Newser
Insider Stock Buying Reaches US$78.0m On Summit Therapeutics - 富途牛牛
Applying Wyckoff theory to Summit Therapeutics Inc. stock2025 Market Outlook & Real-Time Market Trend Scan - Newser
What’s next for Summit Therapeutics Inc. stock priceSwing Trade & Accurate Intraday Trading Signals - Newser
How hedge fund analytics apply to Summit Therapeutics Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
How high can Summit Therapeutics Inc. stock goJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - Newser
Using RSI to spot recovery in Summit Therapeutics Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Is Summit Therapeutics Inc. trending in predictive chart modelsGlobal Markets & High Return Stock Watch Alerts - Newser
Using flow based indicators on Summit Therapeutics Inc.Weekly Stock Analysis & Real-Time Buy Zone Alerts - Newser
3 No-Brainer Stocks to Buy Right Now - The Globe and Mail
Summit Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44 - Yahoo Finance
Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.97%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):